English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessMoneycontrol ResearchSyngene: Preferred CRAMS play for the long term

    Syngene: Preferred CRAMS play for the long term

    The company’s underperformance, compared to the Nifty, is not justified, and there is merit in considering the stock at the current levels. In the medium term, complex APIs and biologics manufacturing would be the growth drivers.

    Anubhav Sahu
    January 03, 2024 / 09:44 IST
    Recent consolidation provides an opportunity to accumulate stock
    • PRO Panorama

      Moneycontrol Pro Panorama | Fiat crisis

      Oct 6, 2025 / 03:28 PM IST

      In Moneycontrol Pro Panorama October 6 edition: India missing out on the emerging markets party, can earnings season revive the ma...

      Read Now
    • PRO Weekender

      Moneycontrol Pro Weekender | When the Ground Shifts

      Sep 27, 2025 / 10:00 AM IST

      In a week where the fault lines of markets, technology, and policy all seemed to move at once, the only certainty is that change i...

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts

    Disclosure & Disclaimer

    This Research Report / Research Recommendation has been published by Moneycontrol Dot Com India Limited (hereinafter referred to as “MCD”) which is a registered Investment Advisor under the Securities and Exchange Board of India (Investment Advisers) ...Read More